Alpine Global Management’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,199
Closed -$262K 246
2024
Q2
$262K Buy
+11,199
New +$262K 0.05% 259